Showa Inan General Hospital

Recent papers from Showa Inan General Hospital

1. Columnar-lined esophagus measuring less than 1 cm as a risk factor for esophageal squamous cell carcinoma in Japanese menJournal of Gastroenterology · 2026
2. Targeted proteomics reveal histiocytosis‐associated neurodegeneration signaturesHemaSphere · 2026
3. Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategiesExpert Review of Anticancer Therapy · 2026
4. Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J)RMD Open · 2026
5. Five‐Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check‐Up Data in Japan: J‐GESS ScoreJournal of Gastroenterology and Hepatology · 2026
6. Selective IL-23 inhibitors in ulcerative colitis: current evidence and perspectives for multimodal personalized treatment: a narrative review.2026
7. Frailty and geriatric complications in older patients with IBD: a nationwide hospital claims database study across Japan.2026
8. Nationwide survey of ruxolitinib administration for Japanese children with hemophagocytic lymphohistiocytosisPediatric Hematology and Oncology · 2026
9. Clinicopathological features of primary cold agglutinin disease in the Japanese population: Heterogeneous characteristics and diagnostic challengesJournal of Clinical and Experimental Hematopathology · 2026
10. Role of glutathione-peroxidase 6 activity in post-COVID-19 olfactory dysfunctionThe Egyptian Journal of Otolaryngology · 2026
11. Histopathological predictor of response to mirikizumab in active ulcerative colitisClinical Journal of Gastroenterology · 2026
12. Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin therapy: a retrospective observational studyJournal of Pharmaceutical Health Care and Sciences · 2026
13. Risk‐Stratified Phase II Clinical Trial for Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in JapanPediatric Blood & Cancer · 2025
14. Risk‐Stratified Phase II Clinical Trial for Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in JapanPediatric Blood & Cancer · 2025
15. Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative ColitisJournal of Clinical Medicine · 2025
16. Does >200 mg of Propofol Sedation Allow Healthy Individuals to Undergo a Colonoscopy and Drive Themselves Home?Journal of Clinical Gastroenterology · 2025
17. Potentially Causal Associations Between Extensive Gastric Atrophy and Esophageal Squamous Cell Carcinoma: A Nationwide Retrospective Cohort Study in JapanDigestive Endoscopy · 2025
18. Assessing the Appropriateness of Helicopter Emergency Medical Services for Non- Traumatic Emergencies in Kochi prefecture, Japan2025
19. Assessment of Ulcerative Colitis Patients with Elevated Neutrophilic Infiltration in the Colonic Mucosal Epithelium Using the Komagane Subclassification of the Geboes Score Grade 3Journal of Clinical Medicine · 2025
20. The Risk of Colonoscopy‐related Bleeding in Patients With or Without Continued Treatment With an Antithrombotic AgentDEN Open · 2025